Powl Brian T.: insider trades.
Powl Brian T. reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($397K), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- Powl Brian T.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Kura Oncology, Inc. (KURA) | Officer · Chief Commercial Officer | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-29 | Kura Oncology, Inc. | S | 15,430 | $10.75 | 136,819 | Form 4 |
| 2026-09-28 | Kura Oncology, Inc. | S | 9,020 | $10.5 | 160,249 | Form 4 |
| 2026-09-28 | Kura Oncology, Inc. | S | 8,000 | $10.56 | 152,249 | Form 4 |
| 2026-08-21 | Kura Oncology, Inc. | S | 4,345 | $11.89 | 169,269 | Form 4 |
Questions
What stock did Powl Brian T. buy or sell?
Powl Brian T. reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($397K), across 1 company.
Is Powl Brian T. the same person as other filers with this name?
This page covers SEC CIK 1934232 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/powl-brian-t-1934232.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.